✦ LIBER ✦

Patterns of adaptation in patients living long term with advanced cancer

✍ Scribed by Julia Hannum Rose; George Kypriotakis; Karen F. Bowman; Douglas Einstadter; Elizabeth E. O'Toole; Rhoderick Mechekano; Neal V. Dawson

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 480 KB
Volume: 115
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.24584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term intravenous hydroxyurea infusi

Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trial

✍ Martin S. Blumenreich; Michael J. Kellihan; U. Geetha Joseph; Kim A. Lalley; Eli 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 1 views

Background. Hydroxyurea is an S-phase specific drug. Constant exposure of tumor cells with a low Sphase fraction to the agent may result in improved cell kill. Because of its short half-life, a continuous intravenous infusion may result in better tumor exposure than intake by mouth. The goal of this

Adjuvant chemotherapy enhances long-term

Adjuvant chemotherapy enhances long-term survival of patients with advanced gastric cancer following curative resection

✍ Yoshihiko Maehara; Sunao Moriguchi; Yoshihisa Sakaguchi; Yasunori Emi; Shunji Ko 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB

Sex or survival : Short-term versus long

Sex or survival : Short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy

✍ Derek R. Wilke; Murray Krahn; George Tomlinson; Andrea Bezjak; Robert Rutledge; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Long-term clinical outcome of pelvic exe

Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies

✍ Christina Fotopoulou; Ulf Neumann; Robert Kraetschell; Joerg C. Schefold; Hennin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Long-term survival of resectable subset

Long-term survival of resectable subset after induction chemotherapy in patients with locally advanced head and neck cancer

✍ Yo-Han Cho; Se Hoon Lee; Dong-Wan Kim; Hong-Gyun Wu; J. Hun Hah; Chae-Seo Rhee; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 1 views

## Abstract ## Background. Although meta‐analysis showed that survival improved with concurrent chemoradiation in locally advanced head and neck cancer, neoadjuvant chemotherapy is still unique, because it renders curative surgery feasible for marginally resectable head and neck cancer patients.

Excess mortality in patients with advanc

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

✍ Adrian M. Di Bisceglie; Anne M. Stoddard; Jules L. Dienstag; Mitchell L. Shiffma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

for the HALT-C Trial Group Chronic hepatitis C virus infection can cause chronic liver disease, cirrhosis and liver cancer. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial was a prospective, randomized controlled study of long-term, low-dose peginterferon therapy in pa